Internal Medicine, Hematology & Oncology · Washington, DC
NPI
1356340517
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3800 Reservoir Rd NW
Washington, DC, 20007
Phone (202) 444-2223
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.5M
1,085,522 services
Medicare patients, 2024
214
Average age 73
Drug cost, 2024
$3.3M
477 prescriptions
Company payments, 2025
$40K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Craig Kessler was code 99215 (office e&m - established), 214 times for 131 patients. In total Craig Kessler billed 1,085,522 services in 20 codes, and Medicare paid $2.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 214 | 131 | $127.09 | $27K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 52 | 40 | $28.85 | $1,500 |
| 99233 Hospital E&M - Subsequent | Facility | 36 | 20 | $108.11 | $3,892 |
| 99223 Hospital E&M - Initial | Facility | 33 | 31 | $159.02 | $5,248 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 32 | 28 | $14.70 | $470 |
| 99205 Office E&M - New | Facility | 29 | 29 | $156.23 | $4,531 |
By year: 2022 $1.1M for 549,541 services; 2023 $2.1M for 929,836 services; 2024 $2.5M for 1,085,522 services.
Medicare prescription drug claims, 2024
In 2024, the drug Craig Kessler prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 85 prescriptions and refills. In total Craig Kessler wrote 477 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jakafi Ruxolitinib Phosphate | 85 | 97 | Under 11 | $1.7M |
| Pegasys Peginterferon Alfa-2a | 65 | 70 | Under 11 | $281K |
| Eliquis Apixaban | 63 | 147 | 18 | $83K |
| Tranexamic Acid Generic | 38 | 42 | 15 | $4,454 |
| Besremi Ropeginterferon Alfa-2b-Njft | 29 | 29 | Under 11 | $494K |
| Xarelto Rivaroxaban | 25 | 73 | Under 11 | $41K |
| Promacta Eltrombopag Olamine | 24 | 24 | Under 11 | $100K |
| Imatinib Mesylate Generic | 24 | 32 | Under 11 | $58K |
| Enoxaparin Sodium Generic | 16 | 30 | Under 11 | $11K |
| Dabigatran Etexilate Dabigatran Etexilate Mesylate | 12 | 28 | Under 11 | $4,030 |
| Doptelet Avatrombopag Maleate | 12 | 20 | Under 11 | $232K |
| Anagrelide Hcl Generic | 12 | 36 | Under 11 | $5,058 |
Brand drugs: 339 claims; generic drugs: 138 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Craig Kessler $40K ($38K in general payments such as food, travel and fees and $2,405 for research) from 15 companies. The largest payer was Pfizer Inc. with $13K.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 5 | $13K |
| Novo Nordisk Inc NVO | 6 | $11K |
| Octapharma USA, Inc. | 9 | $8,694 |
| Regeneron Pharmaceuticals, Inc. REGN | 9 | $7,279 |
| CSL Behring CSL.AX | 1 | $48.47 |
| Genzyme Corporation SNY | 1 | $35.59 |
| Exelixis Inc. EXEL | 1 | $34.38 |
| Daiichi Sankyo Inc. 4568.T | 1 | $29.07 |
| BeOne Medicines USA, Inc. ONC | 1 | $27.8 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $27.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.